Use of99mTc-MIBI scintigraphy in the evaluation of the response of osteosarcoma to chemotherapy
- 1 May 1997
- journal article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 24 (5) , 511-515
- https://doi.org/10.1007/bf01267682
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Technetium-99m sestamibi uptake in human breast carcinoma cell lines displaying glutathione-associated drug-resistanceEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery.American Journal of Roentgenology, 1995
- Treatment of high-grade bone sarcomas with neoadjuvant chemotherapy: the utility of sequential color Doppler sonography in predicting histopathologic response.American Journal of Roentgenology, 1995
- Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 1995
- SPET imaging of intracranial tumours with 99Tcm-sestamibiNuclear Medicine Communications, 1995
- Comparison of technetium-99m methoxyisobutylisonitrile and gallium-67 citrate scanning in the assessment of lymphomasEuropean Journal of Nuclear Medicine and Molecular Imaging, 1995
- Detection of Esophageal Carcinoma Using Tc-99m MIBI SPECT ImagingClinical Nuclear Medicine, 1994
- Monitoring the effect of chemotherapy in Ewing's sarcoma of bone with MR imagingSkeletal Radiology, 1994
- Biological studies of a new class of technetium complexes: the hexakis(alkylisonitrile)technetium(I) cationsInternational Journal of Nuclear Medicine and Biology, 1984
- Radiographic changes in primary osteogenic sarcoma following intensive chemotherapy. Radiological-pathological correlation in 63 patients.Radiology, 1982